» Articles » PMID: 36010641

Expression of IL-37 Induces a Regulatory T-Cell-like Phenotype and Function in Jurkat Cells

Overview
Journal Cells
Publisher MDPI
Date 2022 Aug 26
PMID 36010641
Authors
Affiliations
Soon will be listed here.
Abstract

The anti-inflammatory cytokine interleukin-37 (IL-37) plays a key role in inhibiting innate and adaptive immunity. Past results have shown that IL-37 is elevated in human Treg cells compared to other T cell subsets and contributes to enhancing the Treg transcription factor, forkhead box protein P3 (FOXP3). However, it is unknown if ectopic expression of IL-37 in non-Treg CD4+ T cells can lead to the development of Treg phenotype and function. In the present study, we used a PrimeFlow RNA assay and confirmed elevated expression in human Treg cells. We then stably transfected the non-Treg CD4+ T cell leukemia cell line, E6 Jurkat cells, with and found significant induction of the Treg phenotype. These IL-37-expressing Jurkat cells had elevated CTLA-4 and FOXP3 and produced IL-10. In conjunction with the Treg phenotype, IL-37-expressing Jurkat cells suppressed T cell activation/proliferation, comparable to human primary Treg cells. The creation of this stable human Treg-like cell line has the potential to provide further assistance for in vitro studies of human Treg cells, as it is more convenient than the use of primary human Treg cells. Furthermore, it provides insights into Treg cell biology and function.

Citing Articles

Potential pro-tumour cytokine in oral squamous cellular carcinoma: IL37.

Yan Y, Li J, He Y, Ji P, Xu J, Li Y J Cell Mol Med. 2024; 28(21):e70167.

PMID: 39500733 PMC: 11537803. DOI: 10.1111/jcmm.70167.


The role of IL-37 in gastrointestinal diseases.

Wang Q, Zhang G, An C, Hambly B, Bao S Front Immunol. 2024; 15:1431495.

PMID: 39206201 PMC: 11349528. DOI: 10.3389/fimmu.2024.1431495.


A Narrative Review of the IL-18 and IL-37 Implications in the Pathogenesis of Atopic Dermatitis and Psoriasis: Prospective Treatment Targets.

Rusinol L, Puig L Int J Mol Sci. 2024; 25(15).

PMID: 39126010 PMC: 11312859. DOI: 10.3390/ijms25158437.


Potential Role of IL-37 in Atopic Dermatitis.

Mesjasz A, Trzeciak M, Glen J, Jaskulak M Cells. 2023; 12(23).

PMID: 38067193 PMC: 10706414. DOI: 10.3390/cells12232766.


Alkali-treated titanium dioxide promotes formation of proteoglycan layer and altered calcification and immunotolerance capacity in bone marrow stem cell.

Mizutani T, Tsuchiya S, Honda M, Montenegro Raudales J, Kuroda K, Miyamoto H Biochem Biophys Rep. 2023; 36:101569.

PMID: 38024862 PMC: 10658208. DOI: 10.1016/j.bbrep.2023.101569.


References
1.
Rudloff I, Cho S, Lao J, Ngo D, McKenzie M, Nold-Petry C . Monocytes and dendritic cells are the primary sources of interleukin 37 in human immune cells. J Leukoc Biol. 2016; 101(4):901-911. DOI: 10.1189/jlb.3MA0616-287R. View

2.
Hori S . Lineage stability and phenotypic plasticity of Foxp3⁺ regulatory T cells. Immunol Rev. 2014; 259(1):159-72. DOI: 10.1111/imr.12175. View

3.
Trotta R, Dal Col J, Yu J, Ciarlariello D, Thomas B, Zhang X . TGF-beta utilizes SMAD3 to inhibit CD16-mediated IFN-gamma production and antibody-dependent cellular cytotoxicity in human NK cells. J Immunol. 2008; 181(6):3784-92. PMC: 2924753. DOI: 10.4049/jimmunol.181.6.3784. View

4.
Osborne D, Domenico J, Luo Y, Reid A, Amato C, Zhai Z . Interleukin-37 is highly expressed in regulatory T cells of melanoma patients and enhanced by melanoma cell secretome. Mol Carcinog. 2019; 58(9):1670-1679. PMC: 6692223. DOI: 10.1002/mc.23044. View

5.
Grimsby S, Jaensson H, Dubrovska A, Lomnytska M, Hellman U, Souchelnytskyi S . Proteomics-based identification of proteins interacting with Smad3: SREBP-2 forms a complex with Smad3 and inhibits its transcriptional activity. FEBS Lett. 2004; 577(1-2):93-100. DOI: 10.1016/j.febslet.2004.09.069. View